These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 17310639

  • 1. [The interferon and the antiviral defense].
    Domínguez Carmona M.
    An R Acad Nac Med (Madr); 2006; 123(2):321-39; discussion 340-5. PubMed ID: 17310639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interferons.
    Higgins PG.
    J Clin Pathol; 1984 Feb; 37(2):109-16. PubMed ID: 6198337
    [No Abstract] [Full Text] [Related]

  • 7. Interferon.
    Ho M, Armstrong JA.
    Annu Rev Microbiol; 1975 Feb; 29():131-61. PubMed ID: 1180510
    [No Abstract] [Full Text] [Related]

  • 8. [Interferon and its inducers].
    de Maeyer-Guignard J.
    Rev Prat; 1979 Aug; 29(37):2929-33. PubMed ID: 118508
    [No Abstract] [Full Text] [Related]

  • 9. [Combined use of antiviral preparations].
    Ershov FI, Chizhov NP.
    Vopr Virusol; 1984 Aug; 29(6):644-56. PubMed ID: 6084895
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interferon and its inducers--a never-ending story: "old" and "new" data in a new perspective.
    De Clercq E.
    J Infect Dis; 2006 Sep 15; 194 Suppl 1(Suppl 1):S19-26. PubMed ID: 16921467
    [No Abstract] [Full Text] [Related]

  • 13. The pharmacology and toxicology of the interferons: an overview.
    Mannering GJ, Deloria LB.
    Annu Rev Pharmacol Toxicol; 1986 Sep 15; 26():455-515. PubMed ID: 2424363
    [Abstract] [Full Text] [Related]

  • 14. [Effect of remantadine and ribavirin on the production and antiviral action of human interferon types I and II].
    Nosik DN, Aspetov RD, Novokhatskiĭ AS.
    Antibiotiki; 1982 Jan 15; 27(1):49-54. PubMed ID: 6174074
    [Abstract] [Full Text] [Related]

  • 15. Viruses and interferons.
    Sen GC.
    Annu Rev Microbiol; 2001 Jan 15; 55():255-81. PubMed ID: 11544356
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A.
    J Pharmacol; 1983 Jan 15; 14 Suppl 3():105-16. PubMed ID: 6200731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The drug of first choice: interferon. Clinical pharmacological principles].
    Del Vecchio S, Dianzani F.
    Minerva Gastroenterol Dietol; 1995 Mar 15; 41(1):81-7. PubMed ID: 7542487
    [No Abstract] [Full Text] [Related]

  • 20. Mechanism of antiviral activity in vivo of polycarboxylases which induce interferon production.
    Billiau A, Muyembe JJ, De Somer P.
    Nat New Biol; 1971 Aug 11; 232(2):183-6. PubMed ID: 4998865
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.